Showing results (1271-1280 of 1,376) with videos related to
Sort By:
Pageof 138
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2026
Deep learning-enabled scaffolding of spatial arrays of PfCSP epitopesNelson R Wu, Karla M Castro, Nathan Beutler, et al.Nature Structural & Molecular Biology|May 28, 2013
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120Leopold Kong, Jeong Hyun Lee, Katie J Doores, et al.Nature Structural & Molecular Biology|May 28, 2013
Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16Marie Pancera, Syed Shahzad-Ul-Hussan, Nicole A Doria-Rose, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 4, 2008
Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2)David C Whitcomb, Dhiraj Yadav, Slivka Adam, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2011
Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitorsLorin A Thompson, Jianliang Shi, Carl P Decicco, et al.Biorxiv : the Preprint Server for Biology|February 16, 2022
Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.Cell Reports. Medicine|April 27, 2022
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infectionsAneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, et al.The Journal of Clinical Investigation|March 4, 2025
The saponin monophosphoryl lipid A nanoparticle adjuvant induces dose-dependent HIV vaccine responses in nonhuman primatesParham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, et al.Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.Science Translational Medicine|September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challengeBoris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.Pageof 138